shutterstock_1181693818_scharfsinn
Scharfsinn / Shutterstock.com
1 August 2023FeaturesAsiaKavita Arora and Shaivya Dhavan

3D Bioprinting: Can India capitalise on a growing trend?

The shortage of organ donors and the resulting loss of lives due to tissue damage or organ failure is a global crisis. In India, approximately 500,000 people die annually due to the lack of an organ donor.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
15 October 2019   US biotechnology company Qrons has obtained a world exclusive licence for IP related to 3D printable materials in the fields of human and animal health from Dartmouth University.
Americas
23 October 2018   Maryland-based United Therapeutics has inked a licence, development and commercialisation agreement with CollPlant, an Israeli biotech company, for 3D bioprinted lung transplants.

More on this story

Americas
15 October 2019   US biotechnology company Qrons has obtained a world exclusive licence for IP related to 3D printable materials in the fields of human and animal health from Dartmouth University.
Americas
23 October 2018   Maryland-based United Therapeutics has inked a licence, development and commercialisation agreement with CollPlant, an Israeli biotech company, for 3D bioprinted lung transplants.

More on this story

Americas
15 October 2019   US biotechnology company Qrons has obtained a world exclusive licence for IP related to 3D printable materials in the fields of human and animal health from Dartmouth University.
Americas
23 October 2018   Maryland-based United Therapeutics has inked a licence, development and commercialisation agreement with CollPlant, an Israeli biotech company, for 3D bioprinted lung transplants.